Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
November 13, 2024 at 08:22 AM EST
AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to purchase Summa Health for $485 million.
